Projects
Librexia AF is a randomized, double-blind, double-dummy, parallel group, active-controlled study to evaluate the efficacy and safety of milvexian versus apixaban in participants with atrial fibrillation.
Project Description
Background: The purpose of this study is to evaluate if milvexian is at least as effective as apixaban for reducing the risk of the composite stroke and non- central nervous system (CNS) systemic embolism.
Sample size: Global-50,500 and India-1417
Project Duration
2024 - Ongoing
Project Lead
Dr. Denis Xavier
Authors
Dr. Denis Xavier
Project Status
ongoing
Project Type
2024